Henkjan Verkade

Henkjan Verkade

Rijksuniversiteit Groningen

H-index: 60

Europe-Netherlands

About Henkjan Verkade

Henkjan Verkade, With an exceptional h-index of 60 and a recent h-index of 36 (since 2020), a distinguished researcher at Rijksuniversiteit Groningen,

His recent articles reflect a diverse array of research interests and contributions to the field:

Treatment strategies for hepatic artery complications after pediatric liver transplantation: A systematic review

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review

Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper

Old habits die hard: The age at Kasai portoenterostomy in European infants with biliary atresia

Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

OC7 Maralixibat-treated patients with Alagille syndrome demonstrate event-free survival in a natural history comparison with patients with from the GALA database: application …

Odevixibat treatment induces biliary bile acid secretion in responsive patients with bile salt export pump deficiency

Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70−/− Mice with a Human-like Bile Acid …

Henkjan Verkade Information

University

Position

Professor of Pediatrics University Medical Center Groningen The Netherlands

Citations(all)

13045

Citations(since 2020)

6286

Cited By

9199

hIndex(all)

60

hIndex(since 2020)

36

i10Index(all)

232

i10Index(since 2020)

148

Email

University Profile Page

Rijksuniversiteit Groningen

Google Scholar

View Google Scholar Profile

Top articles of Henkjan Verkade

Title

Journal

Author(s)

Publication Date

Treatment strategies for hepatic artery complications after pediatric liver transplantation: A systematic review

Weihao Li

Reinoud PH Bokkers

Rudi AJO Dierckx

Henkjan J Verkade

Dewey H Sanders

...

2024/2/1

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review

American journal of respiratory and critical care medicine

Matthias Griese

Stefano Costa

Rachel W Linnemann

Marcus A Mall

Edward F McKone

...

2021/2/1

Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper

Journal of Pediatric Gastroenterology and Nutrition

Frank AJA Bodewes

Alvin Jay Freeman

Alexander Weymann

Dominique Debray

Isabelle Scheers

...

2024/1

Old habits die hard: The age at Kasai portoenterostomy in European infants with biliary atresia

Journal of Pediatric Gastroenterology and Nutrition

Willem S Lexmond

Henkjan J Verkade

2024/4/8

Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

The Lancet Gastroenterology & Hepatology

Nadia Ovchinsky

Madeleine Aumar

Alastair Baker

Ulrich Baumann

Philip Bufler

...

2024/4/23

OC7 Maralixibat-treated patients with Alagille syndrome demonstrate event-free survival in a natural history comparison with patients with from the GALA database: application …

BE Hansen

SM Vandriel

P Vig

W Garner

DB Mogul

...

2023/7/1

Odevixibat treatment induces biliary bile acid secretion in responsive patients with bile salt export pump deficiency

Gastroenterology

Mark Nomden

Folkert Kuipers

Jan BF Hulscher

Erik Lindström

Velichka Valcheva

...

2023/8/1

Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70−/− Mice with a Human-like Bile Acid …

Biomedicines

Anna Palmiotti

Hilde D De Vries

Milaine V Hovingh

Martijn Koehorst

Niels L Mulder

...

2023/9/8

Long-term outcome of asymptomatic patients with graft fibrosis in protocol biopsies after pediatric liver transplantation

Transplantation

Steffen Hartleif

James Hodson

Carla Lloyd

Vladimir L Cousin

Piotr Czubkowski

...

2023/11/1

EASL-ERN position paper on liver involvement in patients with Fontan-type circulation

Journal of Hepatology

Luis Téllez

Audrey Payancé

Eric Tjwa

María Jesús Del Cerro

Lars Idorn

...

2023/11/1

Gamma‐glutamyl transferase and disease course in pediatric‐onset primary sclerosing cholangitis: A single‐center cohort study

Health science reports

Besrat Berhane

Patrick F van Rheenen

Henkjan J Verkade

2023/2

Waitlist mortality of young patients with biliary atresia: Impact of allocation policy and living donor liver transplantation

Liver Transplantation

Hedayatullah Esmati

Marieke van Rosmalen

Patrick F van Rheenen

Marieke T de Boer

Aad P van den Berg

...

2023/2/1

Outcomes in adult patients with progressive familial intrahepatic cholestasis treated with odevixibat: subgroup analysis from the PEDFIC 2 study

Journal of Hepatology

Bertrand Roquelaure

Henkjan J Verkade

Kathleen M Loomes

Janis M Stoll

Christine Clemson

...

2023/6/1

Characterization of a novel bile salt export pump deficiency mouse model with the p. E297g mutation

Antonia Felzen

Milaine Hovingh

Rick Havinga

Niels Mulder

Martijn Koehorst

...

2023/6

P1 Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs …

Bettina Hansen

Velichka Valcheva

Qifeng Yu

Daan BE van Wessel

Richard J Thompson

...

2023/9/1

Incidence of Isolated Biliary Atresia during the COVID Lockdown in Europe: Results from a Collaborative Project by RARE-Liver

Journal of Clinical Medicine

Mark Nomden

Naved K Alizai

Pietro Betalli

Janneke LM Bruggink

Mara Cananzi

...

2023/1/18

Genotype-phenotype relationships of truncating mutations, p. E297G and p. D482G in bile salt export pump deficiency

JHEP Reports

Antonia Felzen

Daan BE Van Wessel

Emmanuel Gonzales

Richard J Thompson

Irena Jankowska

...

2023/2/1

OC46 Native liver survival in odevixibat serum bile acid responders: data from PEDFIC studies in patients with progressive familial intrahepatic cholestasis

RJ Thompson

C Clemson

V Valcheva

E Sturm

Q Ni

...

2023/7/1

Odevixibat therapy following liver transplantation in patients with FIC1-deficient progressive familial intrahepatic cholestasis: a retrospective case series

Journal of Hepatology

Georg-Friedrich Vogel

Simone Kathemann

Andrea Pietrobattista

Giuseppe Maggiore

Denise Aldrian

...

2023/6/1

Longitudinal relationship between albuminuria in infancy and childhood

Pediatric Nephrology

Valentina Gracchi

Sophie M van den Belt

Eva Corpeleijn

Dick de Zeeuw

Hiddo JL Heerspink

...

2023/8

See List of Professors in Henkjan Verkade University(Rijksuniversiteit Groningen)